The molecular background of glycogen metabolism disorders

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 3, 1999, Pages 363-379

  Elpeleg, Orly N ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Fanconi Bickel syndrome; Glycogen storage disorders; Glycogen synthase deficiency; Mutation analysis

Indexed keywords

GLUCOSE 6 PHOSPHATASE;

BICKEL SYNDROME; ENZYME ACTIVITY; ENZYME DEFICIENCY; FANCONI ANEMIA; GENE LOCATION; GLYCOGEN METABOLISM; GLYCOGEN STORAGE DISEASE; HUMAN; PROTEIN TERTIARY STRUCTURE; REVIEW;

EID: 0033063194     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.3.363     Document Type: Review

References (131)

1. van Creveld S. Over een bijzondere stoornis in de koolhydraatstof-wisseling in den kinderleeftijd. Nederl Maandschr Geneesk 1928; 8: 349-359.
2. von Gierke E. Hepato-nephromegalia glykogenica. Ziegler's Beitrage pathol Anat u allgem Pathol 1929; 82: 497-513.
3. Arion WJ, Lange AJ, Walls HE, Ballas LM. Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J Biol Chem 1980; 255: 10396-10406.
4. Schulze HU, Nolte B, Kannler R. Evidence for changes in the conformational status of rat liver microsomal glucose-6-phosphate: phosphohydrolase during detergent-dependent membrane modification. Effect of p-mercuribenzoate and organomercurial agarose gel on glucose-6-phosphatase of native and detergent-modified microsomes. J Biol Chem 1986; 261: 16571-16578.
5. Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B Jr, Lee EJ, Westphal H, Mansfield BC, Chou JY. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet 1996; 13: 203-209.
6. Smit GPA. The long-term outcome of patients with glycogen storage disease type 1a. Eur J Pediatr 1993; 152 (Suppl 1): S52-S55.
7. Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 1993; 152 (Suppl 1): S63-S70.
8. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI. Glycogen storage disease in adults. Ann Intern Med 1994; 120: 218-226.
9. Burchell A. Molecular pathology of glucose-6-phosphatase. FASEB J 1990; 4: 2978-2988.
10. Burchell A, Gibb L, Waddell ID, Giles M, Hume R. The ontogeny of human hepatic microsomal glucose-6-phosphatase proteins. Clin Chem 1990; 36: 1633-1637.
11. Brody LC, Abel KJ, Castilla LH, Couch FJ, McKinley DR, Yin G, Ho PP, Merajver S, Chandrasekharappa SC, Xu J, Cole JL, Struewing JP, Valdes JM, Collins FS, Weber BL. Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17. Genomics 1995; 25: 238-247.
12. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 1993; 262: 580-583.
13. Lei KJ, Pan CJ, Shelly LL, Liu JL, Chou JY. Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Clin Invest 1994; 93: 1994-1999.
14. Hemrika W, Wever R. A new model for the membrane topology of glucose-6-phosphatase: the enzyme involved in von Gierke disease. FEBS Lett 1997; 409: 317-319.
15. Pan CJ, Lei KJ, Annabi B, Hemrika W, Chou JY. Transmembrane topology of glucose-6-phosphatase. J Biol Chem 1998; 273: 6144-6148.
16. Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, McConkie-Rosell A, Van Hove JL, Ou HC, Yeh NJ, Pan LY, Chou JY. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 1995; 57: 766-771.
17. Parvari R, Lei KJ, Bashan N, Hershkovitz E, Korman SH, Barash V, Lerman-Sagie T, Mandel H, Chou JY, Moses SW. Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies. Am J Med Genet 1997; 72: 286-290.
18. Lei KJ, Pan CJ, Liu JL, Shelly LL, Chou JY. Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Biol Chem 1995; 270: 11882-11886.
19. Kajihara S, Matsuhashi S, Yamamoto K, Kido K, Tsuji K, Tanae A, Fujiyama S, Itoh T, Tanigawa K, Uchida M, Setoguchi Y, Motomura M, Mizuta T, Sakai T. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type Ia in Japan. Am J Hum Genet 1995; 57: 549-555.
20. Gerin I, Veiga-da-Cunha M, Achouri Y, Collet JF, Van Schaftingen E. Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett 1997; 419: 235-238.
21. Annabi B, Hiraiwa H, Mansfield BC, Lei KJ, Ubagai T, Polymeropoulos MH, Moses SW, Parvari R, Hershkovitz E, Mandel H, Fryman M, Chou JY. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 1998; 62: 400-405
22. Kure S, Suzuki Y, Matsubara Y, Sakamoto O, Shintaku H, Isshiki G, Hoshida C, Izumi I, Sakura N, Narisawa K. Molecular analysis of glycogen storage disease type Ib: identification of a prevalent mutation among Japanese patients and assignment of a putative glucose-6-phosphate translocase gene to chromosome 11. Biochem Biophys Res Comm 1998; 248: 426-431.
23. Nordlie BC, Sukalski KA, Munoz JM, Baldwin JJ. Type Ic, a novel glycogenosis. J Biol Chem 1983; 258: 9739-9744.
24. 2 pyrophosphate/phosphate transport protein is absent. Biochem J 1992; 281: 859-863.
25. Burchell A, Jung RT, Lang CC, Bennet W, Shepherd AN. Diagnosis of type 1a and type 1c glycogen storage diseases in adults. Lancet 1987; i: 1059-1062.
26. Burchell A, Bell J, Busuttil A, Hume R. Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome. Lancet 1989; ii: 291-294.
27. Fenske CD, Jeffery S, Weber JL, Houlston RS, Leonard JV, Lee PJ. Localisation of the gene for glycogen storage disease type 1c by homozygosity mapping to 11q. J Med Genet 1998; 35: 269-272.
28. Veiga-da-Cunha M, Gerin I, Vikkula M, van Schaftingen E. A gene on chromosome 11q23 coding for a putative glucose 6-phosphate translocase is mutated in glycogen storage disease type Ib and type Ic. J Inher Metab Dis 1998; 21 (Suppl 2): 92.
29. Engel AG, Gomez MR, Seybold ME, Lambert EH. The spectrum and diagnosis of acid maltase deficiency. Neurology 1973; 23: 95-106.
30. Engel AG. Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain 1970; 93: 599-616.
31. Wokke JHJ, Ausems MGEM, van den Boogaard MJH, Ippel EF, van Diggelen O, Kroos MA, Boer M, Jennekens FGI, Reuser AJJ, Ploos van Amstel HK. Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 1995; 38: 450-454.
32. Makos MM, McComb RD, Hart MN, Bennett DR. Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship. Ann Neurol 1987; 22: 629-633.
33. Kretzschmar HA, Wagner H, Hubner G, Danek A, Witt TN, Mehraein P. Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci 1990; 98: 169-183.
34. Suzuki Y, Tsuji A, Omura K, Nakamura G, Awa S, Kroos M, Reuser AJJ. Km mutant of acid alpha-glucosidase in a case of cardiomyopathy without signs of skeletal muscle involvement. Clin Genet 1988; 33: 376-385.
35. Isaacs H, Savage N, Badenhorst M, Whistler T. Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures. J Neurol Neurosurg Psychiatry 1986; 49: 1011-1018.
36. Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT. Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995; 3: S61-69.
37. Kuo WL, Hirschhorn R, Huie ML, Hirschhorn K. Localization and ordering of acid alpha-glucosidase (GAA) and thymidine kinase (TK1) by fluorescence in situ hybridization. Hum Genet 1996; 97: 404-406.
38. Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJJ, Oostra BA. Characterization of the human lysosomal alpha-glucosidase gene. Biochem J 1990; 272: 493-497.
39. Hoefsloot LH, Hoogeveen-Westerveld M, Kroos MA, van Beeumen J, Reuser AJJ, Oostra BA. Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J 1988; 7: 1697-1704.
40. Nicolino M, Puech JP, Letourneur F, Fardeau M, Kahn A, Poenaru L. Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients. Biochem Biophys Res Comm 1997; 235: 138-141.
41. Shieh JJ, Lin CY. Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II. Biochem Biophys Res Comm 1996; 219: 322-326.
42. Huie ML, Tsujino S, Brooks SS, Engel A, Elias E, Bonthron DT, Bessley C, Shanske S, DiMauro S, Goto YI, Hirschhorn R. Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/ deletions in the acid alpha-glucosidase locus of patients of differing phenotype. Biochem Biophys Res Comm 1998; 244: 921-927.
43. Hermans MM, Kroos MA, Smeitink JA, van der Ploeg AT, Kleijer WJ, Reuser A. Glycogen storage disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry. Hum Mutat 1998; 11: 209-215.
44. Van der Kraan M, Kroos MA, Joosse M, Bijvoet AG, Verbeet MP, Kleijer WJ, Reuser AJ. Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. Biochem Biophys Res Comm 1994; 203: 1535-1541.
45. Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1(-13T→G) mutation in a majority of patients and a novel IVS10 (+1GT→CT) mutation. Hum Mol Genet 1994; 3: 2231-2236.
46. Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, Raben N. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 1995; 56: 887-897.
47. Shieh JJ, Wang LY, Lin CY. Point mutation in Pompe disease in Chinese. J Inherit Metab Dis 1994; 17: 145-148.
48. Shieh JJ, Lin CY. Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect. Hum Mutat 1998; 11: 306-312.
49. Hug G, Schubert WK. Lysosomes in type II glycogenosis. Changes during administration of an extract from Aspergillus niger. J Cell Biol 1967; 35: C1-C6.
50. Van der Ploeg AT, Kroos MA, Willemsen R, Brons NHC, Reuser AJJ. Intravenous administration of phosphorylated acid α-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. J Clin Invest 1991; 87: 513-518.
51. Yang HW, Kikuchi T, Hagiwara Y, Mizutani M, Chen YT, Van Hove JL. Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts. Pediatr Res 1998; 43: 374-380.
52. Kikuchi T, Yang HW, Pennybacker M, Ichihara N, Mizutani M, Van Hove JLK, Chen YT. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest 1998; 101: 827-833.
53. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 1992; 116: 896-900.
54. Ding JH, de Barsy T, Brown BI, Coleman RA, Chen YT. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 1990; 116: 95-100.
55. Yang-Feng TL, Zheng K, Yu J, Yang BZ, Chen YT, Kao FT. Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics 1992; 13: 931-934.
56. Bao Y, Dawson TL Jr, Chen YT. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5′ flanking region. Genomics 1996; 38: 155-165.
57. Yang BZ, Ding JH, Enghild JJ, Bao Y, Chen YT. Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 1992; 267: 9294-9299.
58. Bao Y, Yang BZ, Dawson TL Jr, Chen YT. Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 1997; 197: 389-398.
59. Liu W, de Castro ML, Takrama J, Bilous PT, Vinayagamoorthy T, Madsen NB, Bleackley RC. Molecular cloning, sequencing, and analysis of the cDNA for rabbit muscle glycogen debranching enzyme. Arch Biochem Biophys 1993; 306: 232-239.
60. Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT. A single-base deletion in the 3′-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur J Hum Genet 1997; 5: 266-270.
61. Shen J, Bao Y, Chen YT. A nonsense mutation due to a single base insertion in the 3′-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa. Hum Mutat 1997; 9: 37-40.
62. Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996; 98: 352-357.
63. -12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 1998; 102: 1-5.
64. Shen J, Liu HM, Bao Y, Chen YT. Polymorphic markers of the glycogen debranching enzyme gene allowing linkage analysis in families with glycogen storage disease type III. J Med Genet 1997; 34: 34-38.
65. Shen J, Liu HM, McConkie-Rosell A, Chen YT. Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers. Prenatal Diag 1998; 18: 61-64.
66. Tang TT, Segura AD, Chen YT, Ricci LM, Franciosi RA, Splaingard ML, Lubinsky MS. Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis. Acta Neuropathol (Berl) 1994; 87: 531-536.
67. van Noort G, Straks W, Van Diggelen OP, Hennekam RC. A congenital variant of glycogenosis type IV. Pediatr Pathol 1993; 13: 685-698.
68. Guerra AS, van Diggelen OP, Carneiro F, Tsou RM, Simoes S, Santos NT. A juvenile variant of glycogenosis IV (Andersen disease). Eur J Pediatr 1986; 145: 179-181.
69. Greene HL, Brown BI, McClenathan DT, Agostini RM Jr, Taylor SR. A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease. Hepatology 1988; 8: 302-306.
70. McConkie-Rosell A, Wilson C, Piccoli DA, Boyle J, DeClue T, Kishnani P, Shen JJ, Boney A, Brown B, Chen YT. Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 1996; 19: 51-58.
71. Servidei S, Riepe RE, Langston C, Tani LY, Bricker JT, Crisp-Lindgren N, Travers H, Armstrong D, DiMauro S. Severe cardiopathy in branching enzyme deficiency. J Pediatr 1987; 111: 51-56.
72. Reusche E, Aksu F, Goebel HH, Shin YS, Yokota T, Reichmann H. A mild juvenile variant of type IV glycogenosis. Brain Dev 1992; 14: 36-43
73. Lossos A, Barash V, Soffer D, Argov Z, Gomori M, Ben-Nariah Z, Abramsky O, Steiner I. Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. Ann Neurol 1991; 30: 655-662.
74. Bruno C, Servidei S, Shanske S, Karpati G, Carpenter S, McKee D, Barohn RJ, Hirano M, Rifai Z, DiMauro S. Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol 1993; 33: 88-93.
75. Thon VJ, Khalil M, Cannon JF. Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast. J Biol Chem 1993; 268: 7509-7513.
76. Bao Y, Kishnani P, Wu JY, Chen YT. Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 1996; 97: 941-948.
77. Lossos A, Meiner Z, Barash V, Soffer D, Schlesinger I, Abramsky O, Argov Z, Shpitzen S, Meiner V. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 1998; 44: 867-872.
78. DiMauro S, Hartlage PL. Fatal infantile form of muscle phosphorylase deficiency. Neurology 1978; 28: 1124-1129.
79. Kost GJ, Verity MA. A new variant of late-onset myophosphorylase deficiency. Muscle Nerve 1980; 3: 195-201.
80. Lebo RV, Anderson LA, DiMauro S, Lynch E, Hwang P, Fletterick R. Rare McArdle disease locus polymorphic site on 11q13 contains CpG sequence. Hum Genet 1990; 86: 17-24.
81. Hwang PK, See YP, Vincentini AM, Powers MA, Fletterick RJ, Crerar MM. Comparative sequence analysis of rat, rabbit, and human muscle glycogen phosphorylase cDNAs. Eur J Biochem 1985; 152: 267-274.
82. Gautron S, Daegelen D, Mennecier F, Dubocq D, Kahn A, Dreyfus JC. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis. J Clin Invest 1987; 79: 275-281.
83. Burke J, Hwang P, Anderson L, Lebo R, Gorin F, Fletterick R. Intron/exon structure of the human gene for the muscle isozyme of glycogen phosphorylase. Proteins 1987; 2: 177-187.
84. Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med 1993; 329: 241-245.
85. el-Schahawi M, Tsujino S, Shanske S, DiMauro S. Diagnosis of McArdle's disease by molecular genetic analysis of blood. Neurology 1996; 47: 579-580.
86. Bartram C, Edwards RH, Clague J, Beynon RJ. McArdle's disease: a nonsense mutation in exon 1of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 1993; 2: 1291-1293.
87. Martinuzzi A, Tsujino S, Vergani L, Schievano G, Cadaldini M, Bartoloni L, Fanin M, Siciliano G, Shanske S, DiMauro S, Angelini C. Molecular characterization of myophosphorylase deficiency in a group of patients from Northern Italy. J Neurol Sci 1996; 137: 14-19.
88. Vorgerd M, Kubisch C, Burwinkel B, Reichmann H, Mortier W, Tettenborn B, Pongratz D, Lindemuth R, Tegenthoff M, Malin JP, Kilimann MW. Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol 1998; 43: 326-331.
89. Sugie H, Sugie Y, Ito M, Fukuda T, Nonaka I, Igarashi Y. Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation. Clin Chim Acta 1995; 236: 81-86.
90. Tsujino S, Shanske S, Nonaka I, Eto Y, Mendell JR, Fenichel GM, DiMauro S. Three new mutations in patients with myophosphorylase deficiency (McArdle disease). Am J Hum Genet 1994; 54: 44-52.
91. Tsujino S, Shanske S, Goto Y, Nonaka I, DiMauro S. Two mutations, one novel and one frequently observed, in Japanese patients with McArdle's disease. Hum Mol Genet 1994; 3: 1005-1006.
92. Tsujino S, Shanske S, Nonaka I, DiMauro S. The molecular genetic basis of myophosphorylase deficiency (McArdle's disease). Muscle Nerve 1995; 3: S23-S27.
93. Kristjansson K, Tsujino S, DiMauro S. Myophosphorylase deficiency: an unusually severe form with myoglobinuria. J Pediatr 1994; 125: 409-410.
94. Hers HG. Etudes enzymatiques sur fragments hepatiques: application a 1a classification des glycogenoses. Revue Int Hepatol 1959; 9: 35-55.
95. Newgard CB, Fletterick RJ, Anderson LA, Lebo RV. The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14. Am J Hum Genet 1987; 40: 351-364.
96. Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet 1998; 7: 865-870.
97. Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet 1998; 62: 785-791.
98. Willems PJ, Gerver WJ, Berger R, Fernandes J. The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr 1990; 149: 268-271.
99. Mizuta K, Hashimoto E, Tsutou A, Eishi Y, Takemura T, Narisawa K, Yamamura H. A new type of glycogen storage disease caused by deficiency of cardiac phosphorylase kinase. Biochem Biophys Res Comm 1984; 119: 582-587.
100. Servidei S, Metlay LA, Chodosh J, DiMauro S. Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency. J Pediatr 1988; 113: 82-5.
101. Davidson JJ, Ozcelik T, Hamacher C, Willems PJ, Francke U, Kilimann MW. cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis. Proc Natl Acad Sci USA 1992; 89: 2096-2100.
102. Hendrickx J, Coucke P, Bossuyt P, Wauters J, Raeymaekers P, Marchau F, Smit GP, Stolte I, Sardharwalla IB, Berthelot J, van den Bergh I, Berger R, Broeckhoven C, Baussan C, Wapenaar M, Fernandes J, Willems PJ. X-linked liver glycogenosis: localization and isolation of a candidate gene. Hum Mol Genet 1993; 2: 583-589.
103. van den Berg IE, van Beurden EA, Malingre HE, van Amstel HK, Poll-The BT, Smeitink JA, Lamers WH, Berger R. X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit. Am J Hum Genet 1995; 56: 381-387.
104. Hendrickx J, Coucke P, Dams E, Lee P, Odievre M, Corbeel L, Fernandes JF, Willems PJ. Mutations in the phosphorylase kinase gene PHKA2 are responsible for X-linked liver glycogen storage disease. Hum Mol Genet 1995; 4: 77-83.
105. Burwinkel B, Amat L, Gray RG, Matsuo N, Muroya K, Narisawa K, Sokol RJ, Vilaseca MA, Kilimann MW. Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. Hum Genet 1998; 102: 423-429.
106. Burwinkel B, Shin YS, Bakker HD, Deutsch J, Lozano MJ, Maire I, Kilimann MW. Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). Hum Mol Genet 1996; 5: 653-658.
107. Hendrickx J, Dams E, Coucke P, Lee P, Fernandes J, Willems PJ. X-linked liver glycogenosis type II (XLG II) is caused by mutations in the PHKA2, the gene encoding the liver a subunit of the phosphorylase kinase. Hum Mol Genet 1996; 5: 649-652.
108. Wullrich A, Harnacher C, Schneider A, Kilimann MW. The multiphosphorylation domain of the phosphorylase kinase aM and aL subunits is a hotspot of differential mRNA processing and of molecular evolution. J Biol Chem 1993; 268: 23208-23214.
109. Francke U, Darras BT, Zander NF, Kilimann MW. Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16q12-q13. Am J Hum Genet 1989; 45: 276-282.
110. Clemens PR, Yamamoto M, Engel AG. Adult phosphorylase b kinase deficiency. Ann Neurol 1990; 28: 529-538.
111. Wehner M, Clemens PR, Engel AG, Kilimann MW. Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. Hum Mol Genet 1994; 3: 1983-1987.
112. Wullrich-Schmoll A, Kilimann MW. Structure of the human gene encoding the phosphorylase kinase β subunit (PHKB). Eur J Biochem 1996; 238: 374-380.
113. Burwinkel B, Maichele AJ, Aagenaes O, Bakker HD, Lerner A, Shin YS, Strachan JA, Kilimann MW. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). Hum Mol Genet 1997; 6: 1109-1115.
114. van den Berg IE, van Beurden EA, de Klerk JB, van Diggelen OP, Malingre HE, Boer MM, Berger R. Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB). Am J Hum Genet 1997; 61: 539-546.
115. Burwinkel B, Kilimann MW. Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease. J Mol Biol 1998; 277: 513-517.
116. Burwinkel B, Moses SW, Kilimann MW. Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB). Hum Genet 1997; 101: 170-174.
117. Wehner M, Kilimann MW. Human cDNA encoding the muscle isoform of the phosphorylase kinase γ subunit (PHKG1). Hum Genet 1995; 96: 616-618.
118. Jones TA, da Cruz e Silva EF, Spurr NK, Sheer D, Cohen PTW. Localisation of the gene encoding the catalytic γ subunit of phosphorylase kinase to human chromosome bands 7p12-q21. Biochim Biophys Acta 1990; 1048: 24-29.
119. Whitmore SA, Apostolou S, Lane S, Nancarrow JK, Phillips HA, Richards RI, Sutherland GR, Callen DF. Isolation and characterization of transcribed sequences from a chromosome 16 hn-cDNA library and the physical mapping of genes and transcribed sequences using a high-resolution somatic cell panel of human chromosome 16. Genomics 1994; 20: 169-175.
120. Burwinkel B, Shiomi S, Al Zaben A, Kilimann MW. Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis. Hum Mol Genet 1998; 7: 149-154.
121. Maichele AJ, Burwinkel B, Maire I, Sovik O, Kilimann MW. Mutations in the testis/liver isoform of the phosphorylase kinase γ subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. Nat Genet 1996; 14: 337-340.
122. Brivet M, Moatti N, Corriat A, Lemonnier A, Odievre M. Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res 1983; 17: 157-161.
123. Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 1997; 17: 324-326.
124. Santer R, Schneppenheim, Dombrowski A, Bakker HD, Brodehl J, Burlina A, Chen YT, Gellissen K, Leonard J, Moses S, Pronicka E, Shin Y, van t'Hoff W, Steinmann S, Schaub J. Mutation analysis in patients with Fanconi-Bickel syndrome. J Inher Metab Dis 1998; 21 (Suppl 2): 86 (abst).
125. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994; 219: 713-725.
126. Fukumoto H, Seino S, Imura H, Seino Y, Eddy RL, Fukushima Y, Byers MG, Shows TB, Bell GI. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 1988; 85: 5434-5438.
127. Orho M, Bosshard NU, Buist NR, Gitzelmann R, Aynsley-Green A, Blumel P, Gannon MC, Nuttall FQ, Groop LC. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest 1998; 102: 507-515.
128. Aynsley-Green A, Williamson DH, Gitzelmann R. Hepatic glycogen synthetase deficiency. Definition of syndrome from metabolic and enzyme studies on a 9-year-old girl. Arch Dis Child 1977; 52: 573-579.
129. Gitzelmann R, Spycher MA, Feil G, Muller J, Seilnacht B, Stahl M, Bosshard NU. Liver glycogen synthase deficiency: a rarely diagnosed entity. Eur J Pediatr 1996; 155: 561-567.
130. Nuttall FQ, Gannon MC, Kubic VL, Hoyt KJ. The human liver glycogen synthase isozyme gene is located on the short arm of chromosome 12. Genomics 1994; 19: 404-405.
131. Mahrenholz AM, Wang YH, Roach PJ. Catalytic site of rabbit glycogen synthase isozymes. Identification of an active site lysine close to the amino terminus of the subunit. J Biol Chem 1988; 263: 10561-10567.